Miriam D Post

11PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 19, 2026
Inhibiting CXCR2 remodels the tumor microenvironment and blunts tumor progression and dissemination of high-grade serous carcinoma.

|Jul 17, 2026
Targeting p300 Reverses Acidic Microenvironment-Induced PARP Inhibitor Resistance.

|May 27, 2026
αKG-mediated carnitine synthesis drives DNA repair via histone acetylation.

|Dec 10, 2024
Serous-like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours.

Gregor Krings, Eliah R Shamir, Marick Laé

|Aug 08, 2024
The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.

Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post

|Jul 10, 2024
Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma.

Ritsuko Iwanaga, Tomomi M Yamamoto, Karina Gomez

Pageof 2

Frequent Collaborators

9 joint publications

Benjamin G Bitler

4 joint publications

Nicole Marjon

4 joint publications

Kimberly R Jordan

4 joint publications

Tomomi M Yamamoto